Completed

A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

I8G-MC-LMDA - ClinicalTrials.gov - NCT02754830

The purpose of this study is to evaluate the safety and tolerability of the study drug, LY3303560, administered either intravenously or subcutaneously, in both healthy participants and patients with Alzheimer's disease. Side effects and laboratory results will be monitored.
How long will I be in the trial?
Your participation could last up to 16 weeks and include 11 visits to the study center, including a 4 day clinical research unit (CRU) stay.
Email
Completed

A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

I8G-MC-LMDA - ClinicalTrials.gov - NCT02754830

The purpose of this study is to evaluate the safety and tolerability of the study drug, LY3303560, administered either intravenously or subcutaneously, in both healthy participants and patients with Alzheimer's disease. Side effects and laboratory results will be monitored.
How long will I be in the trial?
Your participation could last up to 16 weeks and include 11 visits to the study center, including a 4 day clinical research unit (CRU) stay.
Email

Key Requirements

Age :

30+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

30+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Mild Alzheimer's, Mild Cognitive Impairment

What the trial is testing?

interventions example

Could I receive a Placebo?

yes

Enrollment Goal

90

Trial Dates

April 2016 - July 2018

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

30+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Mild Alzheimer's, Mild Cognitive Impairment

What the trial is testing?

interventions example

Could I receive a Placebo?

yes

Enrollment Goal

90

Trial Dates

April 2016 - July 2018

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Memory, Alzheimer’s Disease, and Research Studies

Memory, Alzheimer’s Disease, and Research Studies

With the help of research study participants, we are learning about aging, memory, and potential new approaches to fighting Alzheimer’s disease.
Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?